{"pager":{"page":1,"pageCount":2,"total":100,"pageSize":50},"listGrid":{"metaData":{},"headerWidth":7,"width":7,"title":"Visualization Navigator App Search","height":50,"headers":[{"hidden":false,"meta":false,"name":"uid","column":"uid","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"name","column":"name","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"view_count","column":"view_count","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"date","column":"date","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"type","column":"type","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"user","column":"user","type":"java.lang.String"},{"hidden":false,"meta":false,"name":"sql","column":"sql","type":"java.lang.String"}],"rows":[["n0CaxnRk0Pn","-",18,"2021-11-01","pivot","Sschmidt","enhanced"],["NSG8jerq1TC","0.1 ZHCT Q2 Analytics: TX_PVLS Summaries",311,"2021-12-10","pivot","ttapera","enhanced"],["VEZHtruLVOJ","0-FY19",48,"2021-12-16","dashboard","BMA.DOH","enhanced"],["YRGMN0qUsyY","0. FY19_EDARP_MER_Results",71,"2021-12-17","dashboard","ChristopherMwangi","enhanced"],["VsIhjbfSdTD","10-19 hts vs tx_new",31,"2021-09-21","pivot","J_oche","enhanced"],["uI6rq30s9Uj","10. Entry Verify: PrEP_CURR by 3mo Test Results for EpiC TZ by GT",183,"2021-12-14","pivot","epic_TZ_N","enhanced"],["ho0b0Xg4wQj","10.PMTCT_STAT",89,"2021-07-14","pivot","CHIMBI-ETHICS2","enhanced"],["SF3UUQMqYW0","10.PMTCT_STAT_target",14,"2021-09-21","pivot","CHIMBI-ETHICS2","enhanced"],["ZgghNlJCLWc","10. Targets: Index HTS_TST Targets by Sex for FY22 EpiC TZ ~ GT",30,"2021-06-16","pivot","epic_TZ_N","enhanced"],["Z0dkXYisqQn","1.11.17 DATIM Training",3,"2017-01-11","dashboard","nakaka","enhanced"],["RkVHxfu8LwR","11. Entry Verify: PrEP_CURR by KeyPop Type for EpiC TZ by GT",157,"2021-12-14","pivot","epic_TZ_N","enhanced"],["pDWnvAu2VB8","11.ETHICS_PMTCT_EID",4,"2021-07-17","pivot","CHIMBI-ETHICS2","enhanced"],["c4kspTjo5Wi","11.PMTCT_EID",69,"2021-05-28","pivot","CHIMBI-ETHICS2","enhanced"],["ZqtYgGgddJ4","11.PMTCT_EID_TARGET",18,"2021-05-27","pivot","CHIMBI-ETHICS2","enhanced"],["qRHyrSxLL5s","11.PMTCT_HEI_POS",3,"2021-05-11","pivot","CHIMBI-ETHICS2","enhanced"],["X4mh6aKYO3f","11. Targets: HTS_SELF Targets by Sex for FY22 EpiC TZ ~ GT",20,"2021-06-16","pivot","epic_TZ_N","enhanced"],["NlWTAQUn6yU","123 ABC DEF Tanzania",5,"2021-09-07","chart","datim","enhanced"],["ludbZL7ppxM","12. Entry Verify: KP_PREV by Population Type for EpiC TZ by GT",89,"2021-12-11","pivot","epic_TZ_N","enhanced"],["luEjdVFnlYn","12.PMTCT_FO",35,"2021-07-06","pivot","CHIMBI-ETHICS2","enhanced"],["tETUHtDrIX4","12. Targets: HTS_SELF Targets by Pop Type for FY22 EpiC TZ ~ GT",11,"2021-06-15","pivot","epic_TZ_N","enhanced"],["Q4yC4U0ZBtQ","13. Entry Verify: KP_PREV by Testing Services for EpiC TZ by GT",128,"2021-12-11","pivot","epic_TZ_N","enhanced"],["R3IBkjMWWKW","13.PMTCT_HEI_POS",6,"2021-04-27","pivot","CHIMBI-ETHICS2","enhanced"],["UvnVMBGjriC","13. Targets: HTS_RECENT Targets by Index Mod for FY22 EpiC TZ ~ GT",21,"2021-06-14","pivot","epic_TZ_N","enhanced"],["ceSUX2KCZB8","14.CXCA_TX",7,"2020-10-26","pivot","CHIMBI-ETHICS2","enhanced"],["IxKzobteA0J","14. Entry Verify: PP_PREV by Age/Sex for EpiC TZ by GT",82,"2021-12-11","pivot","epic_TZ_N","enhanced"],["dF5Hc5cbYC2","14. Targets: HTS_RECENT Targets by Mobile Mod for FY22 EpiC TZ ~ GT",15,"2021-06-14","pivot","epic_TZ_N","enhanced"],["X6jn7rzAzq0","15-35gain",4,"2020-07-27","pivot","CHIMBI-ETHICS2","enhanced"],["rNzsyh9OEj4","15. Entry Verify: PP_PREV by Testing Services for EpiC TZ by GT",72,"2021-12-11","pivot","epic_TZ_N","enhanced"],["UHRWwHmF9i6","<15 HTS 15+ YIELD",1,"2020-08-26","chart","Ahmed Mohammed","enhanced"],["mjcCg7SyZvt","15.PMTCT_ART",53,"2021-07-17","pivot","CHIMBI-ETHICS2","enhanced"],["gVOZt7SiRSQ","15. Targets: HTS_RECENT Targets by Pop Type for FY22 EpiC TZ ~ GT",14,"2021-06-14","pivot","epic_TZ_N","enhanced"],["KcK9VW11tv3","16515_test_pivot",37,"2021-11-03","pivot","jpickering","enhanced"],["iPaJudmSrRh","16. Entry Verify: PP_PREV by Pop Type for EpiC TZ by GT",67,"2021-12-11","pivot","epic_TZ_N","enhanced"],["fNzDLbj4mNE","16.TX_NEW",199,"2021-07-19","pivot","CHIMBI-ETHICS2","enhanced"],["kGuh2GRVPUT","16.TX_NEW_TARG",16,"2020-11-23","pivot","CHIMBI-ETHICS2","enhanced"],["iIv8XbdjTjZ","17.TB_ART",66,"2021-07-17","pivot","CHIMBI-ETHICS2","enhanced"],["t9ZtZ2jp3LG","18185-GUYANA",2,"2019-11-18","dashboard","shill1","enhanced"],["zby7CzLv5Cg","18237: Community HST_TST (Mobile)",454,"2021-11-15","pivot","mpingae-d","enhanced"],["lWzG4YjBT5n","18237: Community HTS_INDEX",654,"2021-11-15","pivot","mpingae-d","enhanced"],["okSMgyoiZhH","18237: Community HTS_INDEX (By contacts tested by test result)",536,"2021-11-15","pivot","mpingae-d","enhanced"],["wyaR8Q3jllt","18237: Community Index Testing Cascade",35,"2021-11-15","chart","mpingae-d","enhanced"],["oKHg9iMut2a","18237: Community Index Testing Cascade- By Regions",48,"2021-11-15","chart","mpingae-d","enhanced"],["tnL4GglDek8","18237: Community  Index Testing Results",86,"2021-11-15","chart","mpingae-d","enhanced"],["ok6NWY0hooQ","18237: Community  Mobile Testing- By Reqions",50,"2021-11-15","chart","mpingae-d","enhanced"],["qWXPiO0eTet","18237: Community  Mobile Testing-Quartely",54,"2021-11-15","chart","mpingae-d","enhanced"],["fZOsnFOBovf","18237: CXCA_SCRN",165,"2022-01-01","pivot","mpingae-d","enhanced"],["VdyaMZV0Np4","18237: CXCA_TX: Percentage of cervical cancer screen-positive women who are HIV-positive and on ART eligible for cryotherapy, thermocoagulation or LEEP who received cryotherapy, thermocoagulation or LEEP (Semi-Annually)",273,"2021-12-20","pivot","mpingae-d","enhanced"],["JZOAaaqgEK2","18237: FY20 Q2 Results SC_CURR N CurrentARVBottles ",196,"2021-12-14","pivot","Mmshana","enhanced"],["kGEM6TyRvJx","18237 FY20 Q2  SC_ARVDISP N DispensedARVBottles ",374,"2021-12-14","pivot","Mmshana","enhanced"],["qS7cI0Vh9LZ","18237 FY20Q2  TX_ML AGE",1,"2021-03-03","pivot","CMushi","enhanced"]]}}